Evidence map›Paper›PMID 42770830›Full record

ArticleThe Biochemical journal2026

Structural organization of TAM receptor ectodomains.

Chrystal A Starbird, Yuhong Zuo, Kahlil Walker, Steven E Stayrook, Kathryn M Ferguson

Abstract read
In one paragraph

Article in The Biochemical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chrystal A Starbird *Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, U.S.A.ORCID 0000-0002-1758-3260
Yuhong Zuo *Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, U.S.A.ORCID 0000-0003-1810-4580
Kahlil WalkerDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, U.S.A.ORCID 0000-0003-0603-5792
Steven E StayrookDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, U.S.A.ORCID 0000-0002-1677-8293
Kathryn M FergusonDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, U.S.A.ORCID 0000-0002-7671-5403

Funding

Understanding how membrane composition directs membrane protein structure and functionRM1GM149406 · NIGMS · YALE UNIVERSITY · PI Joel Adam Butterwick, KATHRYN M FERGUSON · 2023 to 2026
$8.4M
Regulation of Tie2 activation by homo- and hetero-oligomerizationR01CA214704 · NCI · YALE UNIVERSITY · PI FERGUSON, KATHRYN M · 2017 to 2021
$1.9M
The Structural Basis of TAM Receptor Oligomerizarion and Co-receptor InteractionsR00GM144683 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI STARBIRD, CHRYSTAL · 2023 to 2025
$740k
Effects of phosphatidylserine and oligomerization on activation mechanisms of TAM receptorsF32GM131460 · NIGMS · YALE UNIVERSITY · PI STARBIRD, CHRYSTAL · 2019 to 2021
$130k
The Structural Basis of TAM Receptor Oligomerizarion and Co-receptor InteractionsK99GM144683 · NIGMS · YALE UNIVERSITY · PI STARBIRD, CHRYSTAL · 2022 to 2022
$97k
HHS | National Institutes of Health (NIH) K99GM144683HHS | National Institutes of Health (NIH) R01CA214704HHS | National Institutes of Health (NIH) RM1GM149406NCI NIH HHS R01 CA214704NIGMS NIH HHS F32 GM131460NIGMS NIH HHS K99 GM144683NIGMS NIH HHS R00 GM144683NIGMS NIH HHS RM1 GM149406
6 · The paper itself

Abstract

TYRO3, AXL, and MERTK, the TAM receptor tyrosine kinases (RTKs), play roles in phagocytosis and negative regulation of immune responses, contributing to homeostasis in many adult tissues. Aberrant TAM signaling leads to diseases including autoimmune disorders, viral infection, inflammation, and cancer. Development of successful drugs targeting TAM receptors is hindered by incomplete knowledge of the receptor activation mechanism. Receptor dimerization is assumed to play a role, as seen for most RTKs. However, full biological responses require the TAM ligands to engage phosphatidylserine in an opposing cell or virus membrane, suggesting a more complex mechanism, possibly involving higher-order receptor oligomerization or clustering. Here, we present an X-ray crystal structure of the ectodomain of MERTK, which adopts a highly curved conformation with key interdomain boundaries stabilized by N-linked glycan moieties. We show that this MERTK extracellular region (ECR) forms a similar conformation in solution using small-angle X-ray scattering (SAXS), which also suggests a flexible ECR. We compare these crystallographic and solution data for MERTK with SAXS and AlphaFold structural predictions for the other two TAM receptors. SAXS data confirm that each TAM ECR has a distinct curvature, with TYRO3 the most bent and AXL relatively straight. This leads us to speculate that these different ectodomain conformations guide receptor-specific functions. The MERTK X-ray crystal structure also suggests a head-to-tail intermolecular interaction between the Ig2 domain of one MERTK and the FNIIIb domain of a second that has intriguing parallels with interactions that have been proposed to regulate Eph receptor clustering.

Indexed as

c-Mer Tyrosine KinaseReceptor Protein-Tyrosine KinasesCrystallography, X-RayHumansModels, MolecularProtein ConformationProtein DomainsScattering, Small Anglec-Mer Tyrosine KinaseMERTK protein, humanReceptor Protein-Tyrosine Kinasescrystallographyectodomainreceptor tyrosine kinasessmall-angle scatteringTAM receptorstransmembrane proteins

Identifiers

PMID42770830
PMCPMC13660871

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.